Xiyan D. Mu

Beijing, 102218, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

STAT3 gene-related hyper-IgE syndrome complicated by pulmonary aspergillosis: a case report

STAT3 gene-related hyper-IgE syndrome complicated by pulmonary aspergillosis: a case report

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 03, 2026

Clinical analysis of comprehensive bronchoscopic interventional therapy for invasive pulmonary aspergillosis

Clinical analysis of comprehensive bronchoscopic interventional therapy for invasive pulmonary aspergillosis

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: May 10, 2026

Combined exposure to flumethrin and hexaconazole induces synergistic oxidative, metabolic, and immune dysregulation in honeybees.

Combined exposure to flumethrin and hexaconazole induces synergistic oxidative, metabolic, and immune dysregulation in honeybees.

Journal: Journal of hazardous materials
Published: May 07, 2026

Clinical, imaging, and pathological features of diffuse alveolar filling diseases

Clinical, imaging, and pathological features of diffuse alveolar filling diseases

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: March 12, 2026

Comparative bronchoscopic manifestations in pulmonary mucormycosis and invasive pulmonary aspergillosis

Comparative bronchoscopic manifestations in pulmonary mucormycosis and invasive pulmonary aspergillosis

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: March 12, 2026

Bisphenol analogs affected hepatic development and disrupted lipid homeostasis in zebrafish larvae.

Bisphenol analogs affected hepatic development and disrupted lipid homeostasis in zebrafish larvae.

Journal: Environmental pollution (Barking, Essex : 1987)
Published: November 04, 2025

Mechanisms and therapeutic strategies of small cell lung cancer transformation from non-small cell lung cancer after EGFR-TKIs treatment

Mechanisms and therapeutic strategies of small cell lung cancer transformation from non-small cell lung cancer after EGFR-TKIs treatment

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: October 10, 2025

The Liquid Crystal Monomer 3cH2B Affects the Visual System via Neural-Cell-Specific Retinoic Acid Disruption in the Optic Tectum.

The Liquid Crystal Monomer 3cH2B Affects the Visual System via Neural-Cell-Specific Retinoic Acid Disruption in the Optic Tectum.

Journal: Environmental science & technology
Published: September 05, 2025

Progressive fibrosing interstitial lung disease which means idiopathic pulmonary fibrosis plus progressive pulmonary fibrosis

Progressive fibrosing interstitial lung disease which means idiopathic pulmonary fibrosis plus progressive pulmonary fibrosis

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 10, 2025

Evaluation of harmful impact of low concentration cylindrospermopsin through zebrafish behavioral endpoints under multiple life stages.

Evaluation of harmful impact of low concentration cylindrospermopsin through zebrafish behavioral endpoints under multiple life stages.

Journal: Journal of hazardous materials
Published: May 23, 2025

Broflanilide induces zebrafish neurobehavioral defects by interfering with synaptic homeostasis.

Broflanilide induces zebrafish neurobehavioral defects by interfering with synaptic homeostasis.

Journal: Aquatic toxicology (Amsterdam, Netherlands)
Published: February 13, 2025

AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer.

AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer.

Journal: Gynecologic oncology
Published: January 23, 2025
Showing 1-12 of 100

Last Updated: 09/26/2026